Cargando…

Occult Hepatitis B: Clinical Viewpoint and Management

Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI...

Descripción completa

Detalles Bibliográficos
Autor principal: Zobeiri, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603201/
https://www.ncbi.nlm.nih.gov/pubmed/23533738
http://dx.doi.org/10.1155/2013/259148
_version_ 1782263647263784960
author Zobeiri, Mehdi
author_facet Zobeiri, Mehdi
author_sort Zobeiri, Mehdi
collection PubMed
description Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI can be both a source of virus contamination in blood and organ donations and the reservoir for full blown hepatitis after reactivation. HBV reactivation depends on viral and host factors but these associations have not been analyzed thoroughly. In OBI, it would be best to prevent HBV reactivation which inhibits the development of hepatitis and subsequent mortality. In diverse cases with insufficient data to recommend routine prophylaxis, early identification of virologic reactivation is essential to start antiviral therapy. For retrieving articles regarding OBI, various databases, including OVID, PubMed, Scopus, and ScienceDirect, were used.
format Online
Article
Text
id pubmed-3603201
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36032012013-03-26 Occult Hepatitis B: Clinical Viewpoint and Management Zobeiri, Mehdi Hepat Res Treat Review Article Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI can be both a source of virus contamination in blood and organ donations and the reservoir for full blown hepatitis after reactivation. HBV reactivation depends on viral and host factors but these associations have not been analyzed thoroughly. In OBI, it would be best to prevent HBV reactivation which inhibits the development of hepatitis and subsequent mortality. In diverse cases with insufficient data to recommend routine prophylaxis, early identification of virologic reactivation is essential to start antiviral therapy. For retrieving articles regarding OBI, various databases, including OVID, PubMed, Scopus, and ScienceDirect, were used. Hindawi Publishing Corporation 2013 2013-03-04 /pmc/articles/PMC3603201/ /pubmed/23533738 http://dx.doi.org/10.1155/2013/259148 Text en Copyright © 2013 Mehdi Zobeiri. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zobeiri, Mehdi
Occult Hepatitis B: Clinical Viewpoint and Management
title Occult Hepatitis B: Clinical Viewpoint and Management
title_full Occult Hepatitis B: Clinical Viewpoint and Management
title_fullStr Occult Hepatitis B: Clinical Viewpoint and Management
title_full_unstemmed Occult Hepatitis B: Clinical Viewpoint and Management
title_short Occult Hepatitis B: Clinical Viewpoint and Management
title_sort occult hepatitis b: clinical viewpoint and management
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603201/
https://www.ncbi.nlm.nih.gov/pubmed/23533738
http://dx.doi.org/10.1155/2013/259148
work_keys_str_mv AT zobeirimehdi occulthepatitisbclinicalviewpointandmanagement